Valsartan/hctz 80mg/12.5mg Tablets

Manufacturer MYLAN /VIATRIS Active Ingredient Valsartan and Hydrochlorothiazide(val SAR tan & hye droe klor oh THYE a zide) Pronunciation val SAR tan & hye droe klor oh THYE a zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Angiotensin II Receptor Blocker (ARB) and Thiazide Diuretic Combination
🤰
Pregnancy Category
Category D (2nd and 3rd trimesters), Category X (1st trimester - generally considered contraindicated throughout pregnancy due to ARB component)
✅
FDA Approved
Apr 1998
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is a combination of two drugs: valsartan, which is an 'ARB' (angiotensin receptor blocker), and hydrochlorothiazide, which is a 'water pill' (diuretic). They work together to relax blood vessels and remove excess fluid from your body, which helps to lower high blood pressure.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
You can take your medication with or without food.
Take your medication at the same time every day to establish a routine.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

Note: This medication may increase the frequency of urination. To minimize sleep disturbances, try to avoid taking it too close to bedtime.

Drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom.
Keep all medications in a safe and secure location, out of reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your doctor or pharmacist.
If you have questions about disposing of your medication, consult with your pharmacist. You may also want to check if there are any drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember.
However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
* Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take exactly as prescribed, usually once daily with or without food.
  • Do not stop taking this medication without consulting your doctor, even if you feel well.
  • Limit sodium intake in your diet as directed by your doctor.
  • Maintain a healthy diet, regular exercise, and manage stress.
  • Avoid potassium supplements or salt substitutes containing potassium unless advised by your doctor.
  • Avoid excessive alcohol consumption, as it can further lower blood pressure.
  • Stand up slowly from a sitting or lying position to avoid dizziness.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Valsartan 80 mg/Hydrochlorothiazide 12.5 mg orally once daily
Dose Range: 80 - 320 mg

Condition-Specific Dosing:

hypertension: Initial dose is typically 80 mg/12.5 mg once daily. May be titrated up to a maximum of Valsartan 320 mg/Hydrochlorothiazide 25 mg once daily based on blood pressure response and tolerability. Not for initial therapy.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment needed (CrCl > 50 mL/min)
Moderate: Caution advised, monitor renal function. Not recommended if CrCl < 30 mL/min.
Severe: Contraindicated (CrCl < 30 mL/min)
Dialysis: Not recommended for patients on dialysis due to lack of data and potential for further renal impairment.

Hepatic Impairment:

Mild: Caution advised, monitor closely. Initial dose of valsartan should not exceed 80 mg in patients with mild-to-moderate hepatic impairment.
Moderate: Caution advised, monitor closely. Initial dose of valsartan should not exceed 80 mg in patients with mild-to-moderate hepatic impairment.
Severe: Contraindicated (e.g., biliary cirrhosis, cholestasis) due to valsartan component.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Valsartan selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues, including vascular smooth muscle and the adrenal gland. This inhibits the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation and reduction in blood pressure. Hydrochlorothiazide is a thiazide diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule, increasing the excretion of sodium, chloride, and water, and to a lesser extent, potassium and magnesium. This reduces plasma volume and peripheral vascular resistance, contributing to its antihypertensive effect.
📊

Pharmacokinetics

Absorption:

Bioavailability: Valsartan: ~23%; Hydrochlorothiazide: 65-75%
Tmax: Valsartan: 2-4 hours; Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Valsartan: Decreases AUC by 48% and Cmax by 59%, but does not significantly affect therapeutic effect. Hydrochlorothiazide: No clinically significant effect.

Distribution:

Vd: Valsartan: ~17 L; Hydrochlorothiazide: 0.8-1.7 L/kg
ProteinBinding: Valsartan: >94%; Hydrochlorothiazide: 40-68%
CnssPenetration: Valsartan: Limited; Hydrochlorothiazide: Limited

Elimination:

HalfLife: Valsartan: ~6 hours; Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Not available
ExcretionRoute: Valsartan: Feces (83%), Urine (13%); Hydrochlorothiazide: Urine (primarily unchanged)
Unchanged: Valsartan: ~13% (urine); Hydrochlorothiazide: >95% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Within 2 hours
PeakEffect: Valsartan: 4-6 hours; Hydrochlorothiazide: 4 hours
DurationOfAction: 24 hours

Safety & Warnings

âš ī¸

BLACK BOX WARNING

When pregnancy is detected, discontinue Valsartan/Hydrochlorothiazide as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Drowsiness
+ Unusual thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Abnormal heartbeat (fast or irregular)
+ Severe dizziness or fainting
+ Increased thirst
+ Seizures
+ Feeling extremely tired or weak
+ Decreased appetite
+ Difficulty urinating or changes in urine output
+ Dry mouth
+ Dry eyes
+ Severe nausea or vomiting
Signs of kidney problems, including:
+ Difficulty urinating
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Swelling in the arms or legs
Eye problems, such as changes in vision or eye pain, which can occur within hours to weeks of starting this medication and may lead to permanent vision loss if left untreated
Rarely, skin cancer has been reported in people taking hydrochlorothiazide; protect your skin from the sun and have regular skin checks as advised by your doctor; report any changes in mole color or size, or new or changing skin growths to your doctor immediately

Other Possible Side Effects

Most people experience no side effects or only mild side effects while taking this medication. However, if you notice any of the following symptoms or if they persist or bother you, contact your doctor or seek medical help:

Dizziness
Headache
Nose or throat irritation

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting (signs of low blood pressure)
  • Swelling of the face, lips, tongue, or throat (signs of angioedema - seek immediate medical attention)
  • Difficulty breathing or swallowing
  • Signs of high potassium (e.g., unusual tiredness, weakness, irregular heartbeats, nausea)
  • Signs of low potassium (e.g., muscle cramps, weakness, irregular heartbeats)
  • Signs of kidney problems (e.g., decreased urination, swelling in feet/ankles, unusual tiredness)
  • Unusual thirst, dry mouth, nausea, vomiting, or muscle pain (signs of electrolyte imbalance)
  • Yellowing of skin or eyes (jaundice)
  • Blurred vision or eye pain (rare, acute angle-closure glaucoma with HCTZ)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
A known sulfa allergy.
Current treatment with dofetilide.
Difficulty urinating.
Concurrent use of a medication containing aliskiren, particularly if you have diabetes or kidney problems.
Breast-feeding, as you should not breast-feed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

To ensure your safety, avoid driving and other activities that require alertness until you understand how this medication affects you. When getting up from a sitting or lying down position, do so slowly to minimize the risk of dizziness or fainting. Be cautious when climbing stairs.

If you have diabetes, closely monitor your blood sugar levels as directed by your healthcare provider. Regularly check your blood pressure as instructed.

Be aware that this medication may cause increased cholesterol and triglyceride levels. If you already have high cholesterol or triglycerides, discuss this with your doctor. Additionally, have your blood work and other laboratory tests done as scheduled by your doctor, and inform all healthcare providers and laboratory personnel that you are taking this medication. Note that this medication may affect certain laboratory test results.

It may take several weeks to experience the full effects of this medication. If you are using a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult with your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.

Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult with your doctor. Also, discuss the use of alcohol, marijuana or other cannabis products, or prescription and OTC medications that may cause drowsiness with your doctor.

In hot weather or during physical activity, be cautious and drink plenty of fluids to avoid dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.

If you are taking cholestyramine or colestipol, consult with your pharmacist about the proper way to take these medications with this drug. Be aware of the potential for gout attacks.

If you have lupus, this medication may cause your condition to become active or worsen. Immediately report any new or worsening symptoms to your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Profound hypotension (low blood pressure)
  • Dizziness
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Electrolyte disturbances (e.g., hypokalemia, hyponatremia)
  • Dehydration

What to Do:

Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is symptomatic and supportive. Induce emesis or perform gastric lavage if ingestion is recent. Administer activated charcoal. Intravenous fluids may be given to support blood pressure. Monitor vital signs and electrolytes closely.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
  • Potassium supplements
  • Other agents that increase serum potassium (e.g., heparin, trimethoprim)
🔴

Major Interactions

  • Lithium (increased lithium levels and toxicity)
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs) including COX-2 inhibitors (reduced antihypertensive effect, increased risk of renal impairment)
  • Angiotensin-converting enzyme (ACE) inhibitors (increased risk of hypotension, hyperkalemia, and renal impairment - dual blockade of RAAS is generally not recommended)
  • Other antihypertensive agents (additive hypotensive effects)
🟡

Moderate Interactions

  • Corticosteroids (enhanced electrolyte depletion, particularly hypokalemia)
  • Barbiturates, narcotics, alcohol (additive orthostatic hypotension)
  • Antidiabetic drugs (thiazides may decrease glucose tolerance, requiring adjustment of antidiabetic dosage)
  • Cholestyramine and colestipol resins (may impair absorption of hydrochlorothiazide)
  • Digitalis glycosides (hypokalemia/hypomagnesemia induced by HCTZ may predispose to digitalis toxicity)
  • Skeletal muscle relaxants, non-depolarizing (enhanced effect)
đŸŸĸ

Minor Interactions

  • Pressor amines (e.g., norepinephrine) (possible decreased response to pressor amines)
  • Allopurinol (increased risk of hypersensitivity reactions to allopurinol)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy

Timing: Prior to initiation

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: To assess baseline electrolyte balance, especially potassium due to ARB/diuretic effects

Timing: Prior to initiation

Renal Function (BUN, Serum Creatinine, eGFR)

Rationale: To assess baseline kidney function, as both components can affect renal hemodynamics and are renally cleared

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, especially given caution in hepatic impairment

Timing: Prior to initiation

Serum Uric Acid

Rationale: Thiazides can increase uric acid levels

Timing: Prior to initiation

Blood Glucose

Rationale: Thiazides can affect glucose metabolism

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly (e.g., weekly after initiation/dose change, then monthly or quarterly)

Target: <130/80 mmHg or individualized

Action Threshold: Persistent elevation above target or symptomatic hypotension

Serum Electrolytes (Potassium, Sodium)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Potassium <3.0 or >5.5 mEq/L; Sodium <130 or >150 mEq/L, or symptomatic changes

Renal Function (BUN, Serum Creatinine, eGFR)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Stable within patient's baseline range

Action Threshold: Increase in serum creatinine >30% from baseline, or eGFR <30 mL/min

Serum Uric Acid

Frequency: Annually or if symptoms of gout develop

Target: Within normal limits

Action Threshold: Symptomatic hyperuricemia or gout flares

Blood Glucose

Frequency: Annually or if patient develops symptoms of hyperglycemia

Target: Fasting <100 mg/dL

Action Threshold: Persistent hyperglycemia, especially in diabetic patients

đŸ‘ī¸

Symptom Monitoring

  • Dizziness
  • Lightheadedness
  • Fatigue
  • Muscle cramps or weakness (signs of electrolyte imbalance)
  • Swelling in ankles/feet (edema)
  • Unusual thirst or dry mouth
  • Changes in urination frequency
  • Signs of allergic reaction (rash, itching, swelling)
  • Signs of angioedema (swelling of face, lips, tongue, throat)

Special Patient Groups

🤰

Pregnancy

Contraindicated. Valsartan, an ARB, can cause fetal injury and death when administered to pregnant women. Hydrochlorothiazide can also cross the placenta and may cause fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions.

Trimester-Specific Risks:

First Trimester: Risk of major congenital malformations (e.g., cardiovascular, CNS) with ARBs, though less established than 2nd/3rd trimester. Generally considered contraindicated.
Second Trimester: Significant risk of fetal injury (e.g., oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, renal failure, death) due to ARB component.
Third Trimester: Significant risk of fetal injury (e.g., oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, renal failure, death) due to ARB component.
🤱

Lactation

Not recommended. Hydrochlorothiazide is excreted in human milk and can suppress lactation. Valsartan is also likely excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 (Moderate risk - potential for adverse effects due to excretion in milk and potential for effects on infant blood pressure/electrolytes).
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

No overall differences in effectiveness or safety have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Start with lower doses and titrate carefully, monitoring renal function and electrolytes closely due to increased susceptibility to adverse effects (e.g., hypotension, electrolyte imbalances, renal impairment).

Clinical Information

💎

Clinical Pearls

  • This combination is not indicated for initial therapy of hypertension. It is typically used when monotherapy with either valsartan or hydrochlorothiazide is insufficient.
  • Monitor for signs of angioedema, a rare but serious side effect, especially with the first few doses.
  • Educate patients on the importance of consistent daily dosing and not missing doses.
  • Advise patients to report any symptoms of electrolyte imbalance (e.g., muscle cramps, weakness, irregular heartbeats, excessive thirst).
  • Caution patients about orthostatic hypotension, especially at the start of therapy, with dose increases, or when standing up quickly.
  • Avoid concomitant use with potassium supplements or potassium-sparing diuretics due to the risk of hyperkalemia from valsartan.
  • Avoid concomitant use with NSAIDs, which can reduce the antihypertensive effect and increase the risk of renal impairment.
🔄

Alternative Therapies

  • Other ARBs (e.g., valsartan monotherapy)
  • Other diuretics (e.g., hydrochlorothiazide monotherapy, loop diuretics)
  • ACE inhibitors (e.g., lisinopril, enalapril)
  • Calcium channel blockers (e.g., amlodipine, nifedipine)
  • Beta-blockers (e.g., metoprolol, carvedilol)
  • Direct renin inhibitors (e.g., aliskiren - generally not recommended in combination with ARBs/ACEIs)
💰

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets (generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, including the amount and time of ingestion.